Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic ...

DURHAM, N.C., June 05, 2018 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to … …read more

Read more here:: Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic …